Labcorp ROE 2010-2024 | LH
Current and historical return on equity (ROE) values for Labcorp (LH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Labcorp ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-03-31 |
$0.43B |
$7.96B |
5.33% |
| 2023-12-31 |
$0.42B |
$7.88B |
4.79% |
| 2023-09-30 |
$0.66B |
$7.87B |
7.13% |
| 2023-06-30 |
$0.83B |
$8.79B |
8.45% |
| 2023-03-31 |
$1.00B |
$10.34B |
9.78% |
| 2022-12-31 |
$1.28B |
$10.10B |
12.39% |
| 2022-09-30 |
$1.76B |
$10.09B |
16.94% |
| 2022-06-30 |
$1.99B |
$10.40B |
19.00% |
| 2022-03-31 |
$2.10B |
$10.72B |
20.10% |
| 2021-12-31 |
$2.38B |
$10.27B |
23.15% |
| 2021-09-30 |
$2.76B |
$10.53B |
27.46% |
| 2021-06-30 |
$2.88B |
$10.25B |
30.34% |
| 2021-03-31 |
$2.64B |
$10.02B |
30.16% |
| 2020-12-31 |
$1.56B |
$9.44B |
19.42% |
| 2020-09-30 |
$0.85B |
$8.24B |
11.20% |
| 2020-06-30 |
$0.36B |
$7.35B |
4.98% |
| 2020-03-31 |
$0.32B |
$7.02B |
4.43% |
| 2019-12-31 |
$0.82B |
$7.57B |
11.34% |
| 2019-09-30 |
$0.76B |
$7.23B |
10.61% |
| 2019-06-30 |
$0.85B |
$7.14B |
11.98% |
| 2019-03-31 |
$0.90B |
$7.11B |
12.65% |
| 2018-12-31 |
$0.88B |
$6.97B |
12.52% |
| 2018-09-30 |
$1.41B |
$7.25B |
20.15% |
| 2018-06-30 |
$1.27B |
$7.04B |
18.80% |
| 2018-03-31 |
$1.22B |
$6.98B |
18.89% |
| 2017-12-31 |
$1.23B |
$6.80B |
20.08% |
| 2017-09-30 |
$0.70B |
$6.13B |
12.16% |
| 2017-06-30 |
$0.71B |
$5.88B |
12.63% |
| 2017-03-31 |
$0.73B |
$5.65B |
13.30% |
| 2016-12-31 |
$0.71B |
$5.51B |
13.24% |
| 2016-09-30 |
$0.66B |
$5.52B |
12.56% |
| 2016-06-30 |
$0.63B |
$5.31B |
12.45% |
| 2016-03-31 |
$0.60B |
$5.17B |
12.10% |
| 2015-12-31 |
$0.44B |
$4.95B |
9.15% |
| 2015-09-30 |
$0.45B |
$4.91B |
10.53% |
| 2015-06-30 |
$0.43B |
$4.77B |
11.56% |
| 2015-03-31 |
$0.40B |
$4.52B |
12.56% |
| 2014-12-31 |
$0.51B |
$2.82B |
19.02% |
| 2014-09-30 |
$0.52B |
$2.77B |
19.85% |
| 2014-06-30 |
$0.53B |
$2.66B |
20.68% |
| 2014-03-31 |
$0.54B |
$2.50B |
21.09% |
| 2013-12-31 |
$0.57B |
$2.49B |
21.83% |
| 2013-09-30 |
$0.57B |
$2.57B |
21.15% |
| 2013-06-30 |
$0.57B |
$2.66B |
20.86% |
| 2013-03-31 |
$0.57B |
$2.78B |
20.95% |
| 2012-12-31 |
$0.58B |
$2.72B |
21.87% |
| 2012-09-30 |
$0.60B |
$2.72B |
22.89% |
| 2012-06-30 |
$0.58B |
$2.63B |
22.73% |
| 2012-03-31 |
$0.55B |
$2.60B |
21.67% |
| 2011-12-31 |
$0.52B |
$2.50B |
20.70% |
| 2011-09-30 |
$0.52B |
$2.54B |
20.66% |
| 2011-06-30 |
$0.52B |
$2.58B |
21.49% |
| 2011-03-31 |
$0.55B |
$2.40B |
23.67% |
| 2010-12-31 |
$0.56B |
$2.47B |
24.56% |
| 2010-09-30 |
$0.57B |
$2.27B |
26.08% |
| 2010-06-30 |
$0.56B |
$2.21B |
26.39% |
| 2010-03-31 |
$0.54B |
$2.16B |
26.16% |
| 2009-12-31 |
$0.54B |
$2.11B |
27.28% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$16.686B |
$12.162B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
